Trials / Completed
CompletedNCT03522051
Assessment of Pulpotomy Procedure Using NeoMTA Plus in Permanent Teeth With Carious Exposure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Jordan University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 7 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Many deep carious teeth are treated unnecessarily by root canal therapy, while with using current techniques and advances in compatible dental materials in addition to better understanding of biological response of the dental pulp, many can be treated conservatively via vital pulp therapy procedures.
Detailed description
Vital pulp therapy is recommended for teeth diagnosed with reversible pulpitis or partially inflamed pulps in which the remaining healthy tissue can be conserved and protected by a biologically active material to generate a hard tissue barrier that seals and protects the pulp from future microbial insult. The aim of this in vivo study is to clinically and radiographically assess the outcome of full pulpotomy using a calcium silicate based material (NeoMTA Plus) in permanent teeth with carious exposure. Ethics approval was obtained from the institutional ethics and research committee, and the patients were informed about details of the treatment and the possible complications. An informed consent was obtained. 120 patients meeting the inclusion criteria will be selected for this study and they will be subsequently followed up clinically and radiographically after 3 months, 6 months, 1 year and yearly afterward for 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | calcium silicate based material, | Its a dental pulp capping material which is biocompatable and induces hard tissue barrier formation |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-06-01
- Completion
- 2021-08-20
- First posted
- 2018-05-11
- Last updated
- 2021-09-16
Locations
1 site across 1 country: Jordan
Source: ClinicalTrials.gov record NCT03522051. Inclusion in this directory is not an endorsement.